Tanya Lewis Insider Trading $REPL Replimune Group, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Tanya Lewis.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Tanya Lewis. Tanya Lewis is VP Regulatory and Quality in VION PHARMACEUTICALS INC ($VION) and EVP, Chief Reg. Affairs in Karyopharm Therapeutics Inc. ($KPTI) and EVP,Chief Reg.&Quality Officer in Karyopharm Therapeutics Inc. ($KPTI) and Chief Dev. Oper. Off. in Replimune Group, Inc. ($REPL) and Director in Replimune Group, Inc. ($REPL).

Tanya Lewis in Replimune Group, Inc.

Trading Symbol: REPL
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Tanya Lewis: Chief Dev. Oper. Off., Director
Holdings: 73,333 shares
Latest Transaction: May 11 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Tanya Lewis in Replimune Group, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, KPTI, REPL, VION

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 11 2021	REPL	Replimune Group, I ...	Lewis Tanya	Chief Dev. Oper. Of ...	Option Exercise	A	33.99	110,000	3,738,900	110,000
May 11 2021	REPL	Replimune Group, I ...	Lewis Tanya	Chief Dev. Oper. Of ...	Grant	A	0.00	73,333	0	73,333	0 to 73.3 K
Apr 05 2021	REPL	Replimune Group, I ...	Lewis Tanya	Director	Option Exercise	A	31.58	16,500	521,070	16,500
Nov 03 2020	REPL	Replimune Group, I ...	Lewis Tanya	Director	Option Exercise	A	42.00	33,000	1,386,000	33,000

Page: 1